138 related articles for article (PubMed ID: 38688637)
41. First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis: A case report and review of the literature.
Zhang C; Kong FW; Wu WB; Zhang M; Yu GM; Wang X; Liu YY
Medicine (Baltimore); 2020 Sep; 99(36):e22128. PubMed ID: 32899099
[TBL] [Abstract][Full Text] [Related]
42. Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma.
Akagi Y; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
Intern Med; 2020 Apr; 59(8):1075-1080. PubMed ID: 32009093
[TBL] [Abstract][Full Text] [Related]
43. Immune Checkpoint Inhibitor-Induced Pure Red Cell Aplasia: A Review of 2 Cases in Metastatic Melanoma.
Rueda Prada L; Gavrancic T; Cadena Sanabria MO; Dumic I; Bourgeois K; King RL; Yan Y
Am J Case Rep; 2023 Nov; 24():e941789. PubMed ID: 37957950
[TBL] [Abstract][Full Text] [Related]
44. Outcomes in Patients With Non-small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy.
Sun L; Davis CW; Hwang WT; Jeffries S; Sulyok LF; Marmarelis ME; Singh AP; Berman AT; Feigenberg SJ; Levin W; Ciunci CA; Bauml JM; Cohen RB; Langer CJ; Aggarwal C
Clin Lung Cancer; 2021 Jan; 22(1):58-66.e3. PubMed ID: 33279417
[TBL] [Abstract][Full Text] [Related]
45. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
[TBL] [Abstract][Full Text] [Related]
46. Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with
Yue D; Qian J; Chen Z; Zhang B; Chen P; Zhang L; Li J; Zhang H; Wang C
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33558279
[TBL] [Abstract][Full Text] [Related]
47. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T; Csőszi T; Özgüroğlu M; Matsubara N; Géczi L; Cheng SY; Fradet Y; Oudard S; Vulsteke C; Morales Barrera R; Fléchon A; Gunduz S; Loriot Y; Rodriguez-Vida A; Mamtani R; Yu EY; Nam K; Imai K; Homet Moreno B; Alva A;
Lancet Oncol; 2021 Jul; 22(7):931-945. PubMed ID: 34051178
[TBL] [Abstract][Full Text] [Related]
48. Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitrs in Lung Cancer: Case Report and Literature Review.
Xie W; Hu N; Cao L
Front Immunol; 2021; 12():790051. PubMed ID: 34956221
[TBL] [Abstract][Full Text] [Related]
49. Delayed immune-related neutropenia with hepatitis by pembrolizumab.
Nakako S; Nakashima Y; Okamura H; Tani Y; Ueda T; Makuuchi Y; Kuno M; Takakuwa T; Nishimoto M; Koh H; Nakamae H; Hino M
Immunotherapy; 2022 Feb; 14(2):101-105. PubMed ID: 34758635
[TBL] [Abstract][Full Text] [Related]
50. Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A.
Sato A; Sano F; Ishii T; Adachi K; Negishi R; Matsumoto N; Okuse C
Clin J Gastroenterol; 2014 Feb; 7(1):74-8. PubMed ID: 24523831
[TBL] [Abstract][Full Text] [Related]
51. Pembrolizumab plus chemotherapy-induced pneumonitis in chemo-naïve patients with non-squamous non-small cell lung cancer: A multicentre, retrospective cohort study.
Fujimoto D; Miura S; Yoshimura K; Wakuda K; Oya Y; Yokoyama T; Yokoi T; Asao T; Tamiya M; Nakamura A; Yoshioka H; Haratani K; Teraoka S; Tokito T; Murakami S; Tamiya A; Itoh S; Yokouchi H; Watanabe S; Yamaguchi O; Tomii K; Yamamoto N
Eur J Cancer; 2021 Jun; 150():63-72. PubMed ID: 33892408
[TBL] [Abstract][Full Text] [Related]
52. Cavitation and fatal hemoptysis after immunotherapy for advanced lung adenocarcinoma: A case report.
Wang R; Li K; Pi J; Meng L; Zhu M
Thorac Cancer; 2020 Sep; 11(9):2727-2730. PubMed ID: 32691523
[TBL] [Abstract][Full Text] [Related]
53. A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia.
Berger M; Amini-Adlé M; Crumbach L; Paubelle E; Dalle S
Eur J Cancer; 2019 May; 112():94-97. PubMed ID: 30954716
[No Abstract] [Full Text] [Related]
54. Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell/histiocyte-rich large B cell lymphoma.
Fujimi A; Kamihara Y; Kanisawa Y; Hashimoto A; Nakajima C; Hayasaka N; Uemura N; Okuda T; Minami S; Iyama S; Takada K; Sato T; Hara A; Iwata Y; Furuichi K; Wada T; Kato J
Int J Hematol; 2014 Nov; 100(5):490-3. PubMed ID: 25096221
[TBL] [Abstract][Full Text] [Related]
55. A case of pulmonary adenocarcinoma showing rapid progression of peritoneal dissemination after immune checkpoint inhibitor therapy.
Shinozaki T; Iwami E; Ikemura S; Matsuzaki T; Nakajima T; Hashimoto K; Terashima T
BMC Cancer; 2018 May; 18(1):620. PubMed ID: 29855288
[TBL] [Abstract][Full Text] [Related]
56. Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.
Kurokawa K; Hara M; Iwakami SI; Genda T; Iwakami N; Miyashita Y; Fujioka M; Sasaki S; Takahashi K
Intern Med; 2019; 58(22):3283-3287. PubMed ID: 31735738
[TBL] [Abstract][Full Text] [Related]
57. [Successful treatment of Guillain-Barré syndrome-like acute inflammatory demyelinating polyneuropathy caused by pembrolizumab with a combination of corticosteroid and immunoglobulins: a case report].
Hashimoto R; Ueda T; Tsuji Y; Otsuka Y; Sekiguchi K; Matsumoto R
Rinsho Shinkeigaku; 2020 Nov; 60(11):773-777. PubMed ID: 33115993
[TBL] [Abstract][Full Text] [Related]
58. Sarcoid-like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab.
Takamori S; Furubayashi N; Taguchi K; Matsubara T; Fujishita T; Ito K; Yamaguchi M; Toyozawa R; Seto T; Negishi T; Nakamura M; Okamoto T
Thorac Cancer; 2021 Jul; 12(14):2122-2125. PubMed ID: 34002950
[TBL] [Abstract][Full Text] [Related]
59. [Comparison of efficacy and safety between domestic immune checkpoint inhibitors and pembrolizumab in the treatment of driver gene-negative advanced non-small cell lung cancer].
Chen YQ; Zhang YD; Yan H; Qin HY; Huang Z; Zhang X; Xiang SQ; Hu XQ; Wu F; Zhang YC; Zeng L; Yang N
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(4):282-289. PubMed ID: 38246773
[No Abstract] [Full Text] [Related]
60. Pure Red Cell Aplasia Induced by Atezolizumab in a Patient with Small-Cell Lung Cancer Successfully Treated with Steroid Therapy: A Case Report.
Kawakado K; Ito S; Kono K; Mitarai Y; Yanagawa T; Nagasaki M
Case Rep Oncol; 2023; 16(1):1592-1597. PubMed ID: 38111856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]